In ALEX2, we found a moderate level of specific IgE in 17% of patients, a high level in 10% of patients, and a very high level in 13% of patients; the significant relation between sensitization to Mal d 1 and severity of AD was confirmed. The gene discussed is MAL; the disease is Alzheimer disease.